Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide, with approximately 20% of patients presenting with metastatic disease at the time of diagnosis. Despite the cancer's long progression ...
Mar 7, 2025
0
1
The term colorectal cancer combines colon and rectal cancer, two parts of the intestine. The first part of the large intestine is called the colon, and the last part refers to the rectum. These two divisions of colorectal ...
Mar 6, 2025
0
0
Once a disease primarily diagnosed after age 50, colorectal cancer is affecting more adults at younger ages: About 1 in 5 colorectal patients are now under the age of 55, and colorectal cancer is now the leading cause of ...
Mar 5, 2025
0
0
We know that a colonoscopy is the most effective tool for the early detection and prevention of colon cancer.
Mar 5, 2025
0
0
Cases of early onset colorectal cancer, occurring in people between the ages of 20 and 45, have increased in recent decades. However, the reason for the uptick in cases is not well understood. Dr. Benjamin Musher, medical ...
Mar 4, 2025
0
1
Cleveland Clinic researchers have developed and validated a prediction model that estimates the risk of developing colorectal cancer and advanced precancerous polyps in adults under 45 years old. The paper appears in Digestive ...
Mar 3, 2025
0
0
Researchers from the University of Toronto have shown how a low-carbohydrate diet can worsen the DNA-damaging effects of some gut microbes to cause colorectal cancer.
Mar 3, 2025
0
176
Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has emerged as a heterogenous disease tightly linked to metabolic dysfunction and has been redefined under ...
Feb 27, 2025
0
1
Colorectal cancer, the second most common cause of cancer-related death, is mainly treated with chemotherapy, but its effectiveness decreases over time due to the progressive resistance of tumor cells.
Feb 26, 2025
0
2
Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, according to a study in preclinical models led by researchers at UT Southwestern Medical Center. The ...
Feb 25, 2025
0
10
